Cancer immunotherapy in routine cost‐effective cancer care?
Abstract Therapy‐triggered autoimmunity and inflammation in many cancer patients, as well as treatment costs, hamper the success of cancer immunotherapy. The study by Pfeiffer et al in this issue of EMBO Molecular Medicine constitutes a clear step towards a more simple, scalable and affordable appro...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Nature
2018-10-01
|
| シリーズ: | EMBO Molecular Medicine |
| オンライン･アクセス: | https://doi.org/10.15252/emmm.201809660 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|